With a growing CAGR, the Biologics Market represents one of the most attractive investment opportunities in the healthcare space today. The transition from chemical drugs to biological products is shifting the revenue models of pharmaceutical firms, with major portfolios increasingly dominated by these high-growth assets. This economic shift is drawing in significant venture capital and private...